Stem cell therapies for biological repair in osteonecrosis: advances, challenges, and clinical insights
-
By
-
Deliang Cheng
-
Xuehai Ou
-
Jiafeng Long
-
Changming Zheng
-
Shaoyan Shi
-
June 8, 2026
-
Clinical Scorecard: Advancements and Obstacles in Stem Cell Treatments for Biological Restoration in Osteonecrosis: Clinical Perspectives
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Ischemia, cellular apoptosis, reduced osteogenic potential, stem cell-mediated repair mechanisms, and vascular compromise. |
| Target Population | |
| Care Setting | |
Key Highlights
- SCT aims to restore cellular and vascular integrity, contrasting with conventional treatments focused on symptom relief.
Guideline-Based Recommendations
Diagnosis
Management
- Core decompression may be beneficial in early stages; pharmacological therapies like bisphosphonates lack regenerative properties.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
SCT aims to augment or replace inadequate progenitor cells to improve healing capacity, particularly in corticosteroid-induced conditions.
Clinical Best Practices
- Focus on early biological intervention to prevent mechanical breakdown, supported by recent clinical studies.
Related Resources & Content
